Efficacy and Safety of IV Sildenafil in the Treatment of Newborn Infants with, or at Risk of, Persistent Pulmonary Hypertension of the Newborn (PPHN): A Multicenter, Randomized, Placebo-Controlled Trial

This publication has 26 references indexed in Scilit:

• Hydrocortisone Normalizes Phosphodiesterase‐5 Activity in Pulmonary Artery Smooth Muscle Cells from Lambs with Persistent Pulmonary Hypertension of the Newborn
  Pulmonary Circulation, 2014
• Oral sildenafil and inhaled iloprost in the treatment of pulmonary hypertension of the newborn
  Pediatric Pulmonology, 2014
• Impact of early surfactant and inhaled nitric oxide therapies on outcomes in term/late preterm neonates with moderate hypoxic respiratory failure
  Journal of Perinatology, 2013
• Beyond Pulmonary Hypertension: Sildenafil for Chronic Lung Disease of Prematurity
  American Journal of Respiratory Cell and Molecular Biology, 2013
• Is sildenafil an effective therapy in the management of persistent pulmonary hypertension?
  Journal of Clinical Neonatology, 2012
• Intravenous Sildenafil in the Treatment of Neonates with Persistent Pulmonary Hypertension
  The Journal of Pediatrics, 2009
• The Use of Sildenafil in Persistent Pulmonary Hypertension of the Newborn
  American Journal of Perinatology, 2009
• Hyperoxia Increases Phosphodiesterase 5 Expression and Activity in Ovine Fetal Pulmonary Artery Smooth Muscle Cells
  Circulation Research, 2008
• Oral Sildenafil in Infants With Persistent Pulmonary Hypertension of the Newborn: A Pilot Randomized Blinded Study
  Pediatrics, 2006
• Inhaled Nitric Oxide in Full-Term and Nearly Full-Term Infants with Hypoxic Respiratory Failure
  New England Journal of Medicine, 1997